UK markets open in 7 hours 31 minutes

Novavax, Inc. (0A3S.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
58.17-0.01 (-0.02%)
At close: 07:08PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.60
52-week change 3-66.95%
S&P500 52-week change 325.01%
52-week high 360.36
52-week low 35.68
50-day moving average 38.08
200-day moving average 38.78

Share statistics

Avg vol (3-month) 3111.02k
Avg vol (10-day) 3117.56k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8123.7M
% held by insiders 14.99%
% held by institutions 157.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.05:1
Last split date 310 May 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -55.41%
Operating margin (ttm)-63.01%

Management effectiveness

Return on assets (ttm)-17.02%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)983.71M
Revenue per share (ttm)9.76
Quarterly revenue growth (yoy)-18.50%
Gross profit (ttm)N/A
EBITDA -510.99M
Net income avi to common (ttm)-545.06M
Diluted EPS (ttm)-17.51
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)568.51M
Total cash per share (mrq)4.06
Total debt (mrq)280.64M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.70
Book value per share (mrq)-5.14

Cash flow statement

Operating cash flow (ttm)-713.97M
Levered free cash flow (ttm)-979.22M